Clinical Trial Update: The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of adding D745 to D150 plus D759 therapy in adults with type 2 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• D150
• D745
• D759 (D759)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED